DELTEX MEDICAL GROUP PLC Anaesthesia and Critical Care 2021 is a great opportunity to talk to haemodynamic monitoring experts Deltex Medical, who will be exhibiting on booth N8-N15 AB15.
Deltex will be showcasing advances on its the unique TrueVue haemodynamic monitoring platform, featuring the powerful Oesophageal Doppler monitoring technology.
With the ability to monitor both blood flow and pressure, it's unsurprising that Oesophageal Doppler is so strongly (and uniquely) supported by a body of clinical evidence, including 24 RCTs.
Clinicians are invited to visit us on booth N8-N15 AB15 to find out about the latest clinical papers and the very latest clinical guidance relating to Oesophageal Doppler.
Our experienced professionals are here to help busy clinicians unleash the power TrueVue. The clinical evidence shows us that using the TrueVue System to haemodynamically manage patients during medium to high-risk surgery, improves outcomes and reduces complications, including AKI and SSI. This can liberate desperately needed capacity and ultimately save money. After all, resource efficiency has never been more important as we face a challenging surgical backlog.
Attachments
- Original document
- Permalink
Disclaimer
Deltex Medical Group plc published this content on 01 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 November 2021 12:56:02 UTC.
